Serial Number
98271002
Owner
Oncocyte CorporationAttorney
Christopher D. Olszyk, Jr.Filing Date
Nov 15, 2023
ONCOTIME Trademark
Serial Number: 98271002
Trademark Classes
Class 1 - Chemicals
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 10 - Medical Apparatus
Surgical, medical, dental and veterinary apparatus and instruments
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Owner Contact Info
Legal Representation
Correspondence Address
Christopher D. Olszyk, Jr. FOX ROTHSCHILD LLP
212 Carnegie Center, Suite 400
Princeton, NJ 08540
United States
Trademark Details
Filing Date
November 15, 2023
Registration Date
Not Registered
Published for Opposition
June 18, 2024
Goods & Services
Research use only chemical reagents for clinical medical or veterinary purposes; diagnostic reagents for medicinal research use
Diagnostic reagents, other than for medical or veterinary purposes; diagnostic reagents for scientific or research use; reagents for scientific or medical research use
Providing reagent sample testing and diagnostic services for others in the field of cancer testing research, tumor testing research, and screening for the purpose of evaluating patient immunotherapy cancer treatment options
Research use only biopsy tests and devices, namely, medical instruments for use in performing biopsies and medical diagnostic apparatus for evaluating appropriate immunotherapy cancer treatments; Research use only cancer screening tests and devices, namely, medical devices for evaluating immunotherapy cancer treatment options; Research use only cancer screening tests and devices, namely, medical devices for matching cancer diagnosis with cancer treatments; Research use only medical diagnostic apparatus for testing a patient's response to various immunotherapy cancer treatment options in order to help determine the most effective course of treatment for that patient
